ATE501276T1 - Verfahren zur gliomdiagnose mit unterscheidung zwischen progressiven und de-novo-formen - Google Patents
Verfahren zur gliomdiagnose mit unterscheidung zwischen progressiven und de-novo-formenInfo
- Publication number
- ATE501276T1 ATE501276T1 AT06779881T AT06779881T ATE501276T1 AT E501276 T1 ATE501276 T1 AT E501276T1 AT 06779881 T AT06779881 T AT 06779881T AT 06779881 T AT06779881 T AT 06779881T AT E501276 T1 ATE501276 T1 AT E501276T1
- Authority
- AT
- Austria
- Prior art keywords
- progressive
- novo
- distinction
- forms
- mammals
- Prior art date
Links
- 208000032612 Glial tumor Diseases 0.000 title abstract 2
- 206010018338 Glioma Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 230000000750 progressive effect Effects 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 title 1
- 201000010915 Glioblastoma multiforme Diseases 0.000 abstract 3
- 241000124008 Mammalia Species 0.000 abstract 3
- 208000005017 glioblastoma Diseases 0.000 abstract 3
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Inspection Of Paper Currency And Valuable Securities (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1975DE2005 | 2005-07-26 | ||
| PCT/IB2006/001986 WO2007012937A2 (en) | 2005-07-26 | 2006-07-20 | Method for diagnosis of glioma distinguishing between progressive and denovo types |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE501276T1 true ATE501276T1 (de) | 2011-03-15 |
Family
ID=37683709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06779881T ATE501276T1 (de) | 2005-07-26 | 2006-07-20 | Verfahren zur gliomdiagnose mit unterscheidung zwischen progressiven und de-novo-formen |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7754426B2 (de) |
| EP (1) | EP1907579B1 (de) |
| JP (1) | JP5025648B2 (de) |
| AT (1) | ATE501276T1 (de) |
| DE (1) | DE602006020576D1 (de) |
| DK (1) | DK1907579T3 (de) |
| WO (1) | WO2007012937A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2240602B1 (de) * | 2008-01-07 | 2013-05-22 | Council of Scientific & Industrial Research | Neue primer zur identifizierung von astrocytom, seinen stufen und glioblastom-prognose |
| US8688224B2 (en) * | 2008-03-07 | 2014-04-01 | Tremont Electric, Inc. | Implantable biomedical device including an electrical energy generator |
| CN102549028B (zh) | 2009-09-30 | 2016-03-02 | 株式会社日本触媒 | 聚丙烯酸(盐)系吸水树脂及其制造方法 |
| EP2552444B1 (de) | 2010-04-01 | 2018-10-10 | Council of Scientific & Industrial Research | Nikotinamidphosphoribosyltransferase (nmprtase)-inhibitor für gliomtherapie |
| WO2019035075A1 (en) | 2017-08-17 | 2019-02-21 | NantOmics, LLC. | DYNAMIC CHANGES IN FREE RNA CIRCULATING NEURAL TUMORS |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020155480A1 (en) * | 2001-01-31 | 2002-10-24 | Golub Todd R. | Brain tumor diagnosis and outcome prediction |
| JP4703567B2 (ja) * | 2003-05-23 | 2011-06-15 | ジェネンテック， インコーポレイテッド | 膠細胞起源の腫瘍の診断と治療のための組成物と方法 |
-
2006
- 2006-07-20 DE DE602006020576T patent/DE602006020576D1/de active Active
- 2006-07-20 EP EP06779881A patent/EP1907579B1/de not_active Not-in-force
- 2006-07-20 AT AT06779881T patent/ATE501276T1/de not_active IP Right Cessation
- 2006-07-20 WO PCT/IB2006/001986 patent/WO2007012937A2/en not_active Ceased
- 2006-07-20 DK DK06779881.9T patent/DK1907579T3/da active
- 2006-07-20 JP JP2008523476A patent/JP5025648B2/ja not_active Expired - Fee Related
- 2006-07-21 US US11/491,520 patent/US7754426B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP1907579A2 (de) | 2008-04-09 |
| DE602006020576D1 (de) | 2011-04-21 |
| EP1907579B1 (de) | 2011-03-09 |
| WO2007012937A2 (en) | 2007-02-01 |
| WO2007012937B1 (en) | 2007-07-26 |
| US7754426B2 (en) | 2010-07-13 |
| JP5025648B2 (ja) | 2012-09-12 |
| DK1907579T3 (da) | 2011-06-27 |
| JP2009512420A (ja) | 2009-03-26 |
| WO2007012937A3 (en) | 2007-05-18 |
| US20070072216A1 (en) | 2007-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1120961T1 (el) | Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος | |
| CY1121872T1 (el) | Αξιολογηση, δοκιμασιες και θεραπεια των pkal-μεσολαβουμενων διαταραχων | |
| CY1118530T1 (el) | Glyx-13 για χρηση σε μεθοδο θεραπευτικης αγωγης ανθεκτικης σε θεραπεια καταθλιψης | |
| WO2008070137A3 (en) | Interferon alpha-induced pharmacodynamic markers | |
| WO2008137838A3 (en) | Interferon alpha-induced pharmacodynamic markers | |
| UA96139C2 (uk) | Антитіло до нейропіліну-1 (nrp1) | |
| EP2061907A4 (de) | Tcl1-expression in durch mir-29 und mir-181 regulierter chronischer lymphozyten-leukämie (cll) | |
| ATE537450T1 (de) | Igfbp2-biomarker | |
| NO345046B1 (no) | Oral doseringsform | |
| EA200870185A1 (ru) | Комбинации ингибиторов ang2 и vegf | |
| CY1111896T1 (el) | Απαραβιαστες φαρμακευτικες μορφες δοσολογιας δια του στοματος περιλαμβανουσες ενα οπιουχο αναλγητικο | |
| CY1119513T1 (el) | Μεθοδοι και συνθεσεις για την διαγνωση και την θεραπευτικη αγωγη δευτερογενους αυτοανοσης νοσου της πολλαπλης σκληρυνσης | |
| ATE553778T1 (de) | Für humanes hepcidin spezifische antikörper | |
| ATE424560T1 (de) | Marker für neuromyelitis optica | |
| ECSP066559A (de) | ||
| TW200723488A (en) | Diagnostic circuit and method therefor | |
| CY1116083T1 (el) | Μεθοδος για τον εντοπισμο τυπων του ιου των ανθρωπινων θηλωματων (hpv) | |
| EP2406401A4 (de) | Verfahren zur identifizierung, beurteilung, prävention und behandlung von lungenerkrankungen sowie kits dafür mit geschlechtsspezifischer krankheitsidentifizierung, beurteilung, prävention und behandlung | |
| UY29995A1 (es) | Uso de un antagonista de cb1 para tratar efectos secundarios y síntomas negativos de la esquizofrenia | |
| EA200800667A1 (ru) | Аптамеры, связывающие тромбин с высокой аффинностью | |
| EP2145181A4 (de) | Verfahren für die diagnose und das risikomanagement von plasmalogenmangelbedingten alterserkrankungen | |
| ATE445402T1 (de) | Neue verwendung von pde5-hemmern | |
| UY28344A1 (es) | Nuevos compuestos | |
| ATE549416T1 (de) | Verfahren und zusammensetzungen zum nachweis von autoimmunkrankheiten | |
| ATE501276T1 (de) | Verfahren zur gliomdiagnose mit unterscheidung zwischen progressiven und de-novo-formen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |